Literature DB >> 30564997

Secretory Carcinoma of the Thyroid Gland: Report of a Highly Aggressive Case Clinically Mimicking Undifferentiated Carcinoma and Review of the Literature.

Megan A Desai1, Mitra Mehrad1, Kim A Ely1, Justin A Bishop2, James Netterville3, Joseph M Aulino4, James S Lewis5,6.   

Abstract

After being described in the salivary glands as a malignancy with features essentially identical to those of the breast, secretory carcinoma (SC) (formerly mammary analogue SC) has now been identified in other sites including the skin, lung, and thyroid gland. In the breast, SC has a relatively favorable prognosis. Likewise when arising in the salivary glands, it is generally considered to be a low to intermediate grade carcinoma; however, there is a range of clinical behavior with occasional patients dying of progressive disease. SCs of the thyroid gland are rare, and reports suggest a relatively aggressive behavior, at least relative to well differentiated carcinomas such as papillary carcinoma and minimally invasive follicular carcinoma. We present a patient with a highly aggressive thyroid gland SC that mimicked undifferentiated carcinoma clinically. The patient had widespread metastatic disease and died rapidly from airway compromise. We also review the literature for reported cases of thyroid gland SC in order to better establish the clinical features and expected clinical course of such tumors occurring at this site.

Entities:  

Keywords:  Anaplastic carcinoma; ETV6 gene rearrangement; Mammary analogue secretory carcinoma; Papillary carcinoma; Thyroid

Mesh:

Year:  2018        PMID: 30564997      PMCID: PMC6854196          DOI: 10.1007/s12105-018-0995-2

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  2 in total

1.  NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.

Authors:  Manju L Prasad; Monika Vyas; Matthew J Horne; Renu K Virk; Raffaella Morotti; Zongzhi Liu; Giovanni Tallini; Marina N Nikiforova; Emily R Christison-Lagay; Robert Udelsman; Catherine A Dinauer; Yuri E Nikiforov
Journal:  Cancer       Date:  2016-01-19       Impact factor: 6.860

2.  Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.

Authors:  Alena Skálová; Tomas Vanecek; Radek Sima; Jan Laco; Ilan Weinreb; Bayardo Perez-Ordonez; Ivo Starek; Marie Geierova; Roderrick H W Simpson; Fabricio Passador-Santos; Ales Ryska; Ilmo Leivo; Zdenek Kinkor; Michal Michal
Journal:  Am J Surg Pathol       Date:  2010-05       Impact factor: 6.394

  2 in total
  5 in total

Review 1.  Salivary-Like Tumors of the Thyroid: A Comprehensive Review of Three Rare Carcinomas.

Authors:  Meagan Chambers; Vânia Nosé; Peter M Sadow; Laura J Tafe; Darcy A Kerr
Journal:  Head Neck Pathol       Date:  2020-06-19

2.  (Mammary Analogue) Secretory Carcinoma of the Nasal Cavity: Report of a Rare Case with p63 and DOG1 Expression and Uncommon Exon 4-Exon 14 ETV6-NTRK3 Fusion Diagnosed with Next Generation Sequencing.

Authors:  Bingcheng Wu; Thomas Kwok Seng Loh; Tomas Vanecek; Michal Michal; Fredrik Petersson
Journal:  Head Neck Pathol       Date:  2019-07-04

Review 3.  Overview of the 2022 WHO Classification of Thyroid Neoplasms.

Authors:  Zubair W Baloch; Sylvia L Asa; Justine A Barletta; Ronald A Ghossein; C Christofer Juhlin; Chan Kwon Jung; Virginia A LiVolsi; Mauro G Papotti; Manuel Sobrinho-Simões; Giovanni Tallini; Ozgur Mete
Journal:  Endocr Pathol       Date:  2022-03-14       Impact factor: 3.943

4.  Kinase fusion-related thyroid carcinomas: distinct pathologic entities with evolving diagnostic implications.

Authors:  Ying-Hsia Chu; Peter M Sadow
Journal:  Diagn Histopathol (Oxf)       Date:  2021-03-31

5.  Secretory Carcinoma of the Thyroid in a 49-Year-Old Man Treated with Larotrectinib: Protracted Clinical Course of Disease Despite the High-Grade Histologic Features.

Authors:  Maelle Saliba; Abhinita S Mohanty; Alan L Ho; Alexander Drilon; Snjezana Dogan
Journal:  Head Neck Pathol       Date:  2021-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.